ロード中...
The plasma and cerebrospinal fluid pharmacokinetics of sorafenib after intravenous administration in non-human primates
Purpose Sorafenib is a small molecule inhibitor of multiple signaling kinases thought to contribute to the pathogenesis of many tumors including brain tumors. Clinical trials with sorafenib in primary and metastatic brain tumors are ongoing. We evaluated the plasma and cerebrospinal fluid (CSF) phar...
保存先:
| 出版年: | Invest New Drugs |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2010
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6636925/ https://ncbi.nlm.nih.gov/pubmed/21072558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-010-9585-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|